Skip to main content
$195.03 $2.71 (1.4%)

02:01 PM EDT on 05/13/21

ResMed, Inc. (NYSE:RMD)

CAPS Rating: 4 out of 5

The Company is a developer, manufacturer and distributor of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders.

Current Price $195.03 Mkt Cap $28.0B
Open $193.50 P/E Ratio 61.06
Prev. Close $192.32 Div. (Yield) $1.56 (0.8%)
Daily Range $193.00 - $195.67 Volume 283,002
52-Wk Range $149.16 - $224.43 Avg. Daily Vol. 620,198

Caps

How do you think NYSE:RMD will perform against the market?

Add Stock to CAPS Watchlist

All Players

280 Outperform
13 Underperform
 

All-Star Players

86 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSE:RMD Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TMFSpiffyPop (99.86)
Submitted April 26, 2017

Picked on my 4/19/17 Rule Breaker Investing podcast as as a stock I like for the next three years. Outperform.

1simplemind (31.14)
Submitted November 29, 2007

I am a Medicare provider of ResMed's line of products and have done so for the past 8 years. Medicare and the other insurers are shrinking the reimbursements to providers of this product (me) as the boomer population increases. Watch for the margins… More

Recent Community Commentary

Read the most recent pitches from players about RMD.

Recs

0
Member Avatar TMFjimhalley (50.26) Submitted: 4/12/2021 7:40:48 PM : Outperform Start Price: $198.07 NYSE:RMD Score: -1.18

The growth of diagnosis in sleep apnea bodes well for the company. In addition, a lot of sleep apnea diagnoses were put off last year and that will help the company's bottom line this year.

Recs

0
Member Avatar chessNstocks (< 20) Submitted: 2/26/2021 7:44:45 AM : Outperform Start Price: $194.83 NYSE:RMD Score: -6.59

Fool favorite that meets all my Buy criteria.
Price/Sales (TTM) = 9.1
Revenue Growth (5YR) = 12%
Rev Change (Last Qtr vs Prior year Qtr) = 8.7%

Recs

0
Member Avatar IndyAnthony (36.40) Submitted: 2/2/2021 11:30:11 PM : Outperform Start Price: $203.88 NYSE:RMD Score: -11.56

RMD has outperformed the market over the last 10 years and currently sports profit margins > +20% with operating margin and ROE > +27%. Winners keep on winning and RMD should keep compounding. One area of concern to keep eyes on is low inside ownership and high institutional ownership...

Leaderboard

Find the members with the highest scoring picks in RMD.

Score Leader

macchiatto

macchiatto (61.42) Score: +913.94

The Score Leader is the player with the highest score across all their picks in RMD.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
macchiatto 61.42 7/17/2008 Outperform 3M $15.56 +1,152.79% +238.85% +913.94 0 Comment
chipiii3 < 20 6/16/2008 Outperform 3W $16.46 +1,084.36% +212.65% +871.71 0 Comment
rylin100 81.47 6/2/2008 Outperform NS $16.72 +1,066.20% +203.98% +862.22 0 Comment
AIAbram < 20 8/4/2008 Outperform 3W $16.26 +1,098.90% +238.62% +860.28 0 Comment
schwah9 61.44 10/13/2008 Outperform NS $14.99 +1,200.71% +347.96% +852.75 0 Comment
raideral < 20 7/2/2008 Outperform 1Y $16.68 +1,068.60% +228.02% +840.58 0 Comment
alpot 39.59 7/2/2008 Outperform 1Y $16.68 +1,068.60% +228.02% +840.58 0 Comment
aussiepie28 < 20 10/5/2007 Outperform 5Y $17.48 +1,015.19% +177.01% +838.18 1 Comment
brodie82 75.52 7/9/2008 Outperform 1Y $16.69 +1,068.32% +231.71% +836.61 0 Comment
bcorbett8769 52.39 7/2/2008 Outperform 1Y $16.71 +1,066.65% +230.28% +836.37 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for RMD.